Publication Month: Jul 2022 |
Report Code: TIPRE00029525
| No. of Pages:
| Category: Medical Device
| Status: Published
No. of Pages 257
Neonatal care equipment is used to care for small and sick neonates to keep them warm, track their growth, treat jaundice, and provide oxygen or respiratory support. The infants are taken care of by using various devices such as electric warmers, neonatal ventilators, continuous positive airway pressure devices, blood pressure monitors, cardiac monitors, pulse oximeters, capnographs, integrated monitoring devices, and other devices.
The report offers insights and in-depth analysis of the global neonatal care equipment market, emphasizing various parameters, such as market trends, technological advancements, and market dynamics. It also provides the competitive landscape analysis of leading market players and the impact of the COVID-19 pandemic on the market across all major regions.
|Market Size Value in||US$ 1,934.24 Million in 2021|
|Market Size Value by||US$ 3,103.81 Million by 2028|
|Growth rate||CAGR of 7.0% from 2022 to 2028|
|No. of Pages||257|
|No. of Tables||165|
|No. of Charts & Figures||90|
|Historical data available||Yes|
|Segments covered||Product, End User, and Geography|
|Regional scope||North America; Europe; Asia Pacific; Latin America; MEA|
|Country scope||US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
The cost of overall healthcare is surging significantly in North America. The US health system incurred a direct cost of US$ 5.3 billion in 2020. The healthcare system contributed US$ 60 billion in addition to the overall annual costs of the country in 2020. Over 40% of the population in North America canceled their appointments in 2020, and 13% reported that they needed care but did not schedule or receive care. The COVID-19 pandemic altered economic conditions and social behaviors in North American countries. Containment measures enacted by governments to mitigate the spread of disease changed the US healthcare service delivery pattern. According to the Department of Emergency Medicine, in many cities across the country, emergency department (ED) visits decreased by ~40% in 2020. Moreover, outpatient appointments and elective treatments were postponed or replaced by telemedicine practices.
In November 2021, Pfizer Inc. announced the investigational COVID-19 oral antiviral candidate, PAXLOVID. Based on an interim analysis of the Phase 2/3 Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients (EPIC-HR), a randomized, double-blind study of non-hospitalized adult COVID-19 patients who were at a high risk of progressing to severe illness, the PAXLOVID vaccine reportedly reduced hospitalization and death. There were supply constraints related to vaccine production in the initial months of 2021. However, setting up new plants and promoting technological shifts are the strategies that support the production of booster doses in the US and Canada, along with their administration plans.
Premature infants and term infants with medical disorders requiring prolonged hospitalization are prone to hospital-acquired (nosocomial) infection; thus, the adoption of neonatal care equipment in baby care facilities was adversely affected in the wake of the COVID-19 outbreak. Therefore, the financial crisis among the masses in North America is projected to hamper the growth of the neonatal care equipment market
Based on region, the global neonatal care equipment market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America.
The increase in preterm and low-weight births is one of the major factors driving the growth of the fetal and neonatal care devices market. With the increasing number of births, many complications are associated with prematurity, resulting in neonatal deaths. Prematurity is defined as a live birth before 37 weeks of gestation, with a birth weight of less than 2500 g being considered a low weight birth. According to a study published in the July 2020 International Journal of Gynecology & Obstetrics, titled "Global Burden of Preterm Birth," around 15 million babies are born prematurely worldwide, resulting in a global preterm birth rate of approximately 11%. Additionally, in the US, according to the Centers for Disease Control and Prevention, a November 2021 updated article titled "Preterm Birth" reported that one in 10 children born in 2020 was born prematurely. In addition, the incidence of diseases in newborns also increased. These factors increased the market demand for fetal and neonatal care equipment.
Preterm birth remains a significant public health problem, contributing to 75% of worldwide neonatal mortality. Low birth weight (LBW) is an important but imperfect surrogate for preterm birth when the accurate determination of gestational age is impossible. While there is overlap between preterm births and LBW newborns, those who are both preterm and LBW are at the highest risk for adverse neonatal outcomes. The World Health Organization (WHO) estimates that over 15 million infants are born prematurely yearly, and around 1 million die from premature problems. According to the World Health Organization, more than 60% of preterm births occur in South Asia and Africa. The preterm birth rate in low-income countries was around 12%, compared to 9% in higher-income countries. Approximately 3,519,100 preterm births were recorded in India in 2018. The increasing prevalence of hypothermia in preterm infants is a significant public health concern. The World Health Organization has reported it as a leading cause of neonatal mortality and morbidity. Common causes of premature birth are infections, chronic diseases such as high blood pressure and diabetes, and multiple pregnancies; however, often, no cause is identified. Therefore, the increasing number of preterm births and increased survival concerns have fueled the demand for neonatal care equipment to manage the complications associated with preterm birth.
Based on product, the global neonatal care equipment market is segmented infant warmers, neonatal incubators, convertible warmers & incubators, neonatal phototherapy equipment, respiratory care devices, neonatal monitoring devices, neonatal diagnostic imaging devices, and other care equipments. In 2021, the neonatal respiratory care devices segment accounted for the largest market share. The market position of this segment is due to the rising cases of respiratory distress syndrome in newborns.
Based on the end user, the global neonatal care equipment market is categorized into hospitals, paediatric and neonatal clinics, and nursing homes. The hospitals segment hold the largest market share in 2021.
By Geography, North America is further segmented into the US, Canada, and Mexico. Europe is bifurcated into France, Germany, Italy, the UK, Spain, and the Rest of Europe. APAC is divided into China, India, South Korea, Japan, Australia, and the Rest of APAC. The Middle East and Africa is segmented into South Africa, Saudi Arabia, UAE, and the Rest of the MEA. South and Central America is segmented into Brazil, Argentina, and the Rest of SAM.
Some of the major players contributing in the neonatal care equipment market are GE Healthcare, Koninklijke Philips N.V., Medtronic, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, Natus Medical Incorporated, Fisher & Paykel Healthcare Limited, Massimo, BD, and Novos.